3.3 Malnutrition Inflammation Score (MIS) & Scoring Protocols
Key Takeaways
The Malnutrition Inflammation Score (MIS) is a comprehensive, 10-component quantitative scoring system (range 0–30) developed by Kalantar-Zadeh that integrates the subjective elements of SGA with objective measures: BMI, serum albumin, and serum TIBC.
In the MIS framework, serum Total Iron Binding Capacity (TIBC) serves as an objective, non-invasive surrogate for transferrin and visceral protein reserves, dropping sharply during protein depletion and cytokine-driven inflammation.
Each of the 10 MIS components is scored from 0 (normal) to 3 (severely abnormal), and higher totals (studies often use cutoffs such as above 8) indicate more severe protein-energy wasting and inflammation.
Higher MIS scores independently predict ESA hyporesponsiveness, hospitalization and mortality in dialysis cohorts; KDOQI 2020 (statement 1.5.2, grade 2C) says the MIS may be used in maintenance hemodialysis and after transplant.
Compared to the qualitative 7-point SGA and the categorical ISRNM PEW criteria, the MIS offers a granular, continuous numerical scale superior for tracking longitudinal responses to nutritional and anti-inflammatory therapies.
Malnutrition Inflammation Score (MIS) & Scoring Protocols
Core Clinical Principle: The Malnutrition Inflammation Score (MIS) is the first fully quantitative, nephrology-specific scoring system that directly links somatic protein-energy wasting with systemic microinflammation. By combining the historical and physical examination domains of Subjective Global Assessment with three objective markers—Body Mass Index, serum albumin, and serum total iron binding capacity (TIBC)—the MIS generates a continuous composite score (0 to 30) that offers unmatched prognostic accuracy for hospitalization and mortality in end-stage renal disease.
Developed in 2001 by Dr. Kamyar Kalantar-Zadeh and colleagues, the MIS was engineered to overcome the primary limitation of conventional nutritional tools: their inability to account for the Malnutrition-Inflammation Complex Syndrome (MICS), also termed the Malnutrition-Inflammation-Atherosclerosis (MIA) syndrome. In dialysis patients, protein wasting and chronic microinflammation are inextricably linked; inflammation drives hypercatabolism and suppresses hepatic protein synthesis, while nutritional depletion impairs immunocompetence. The MIS captures both axes in a standardized, reproducible bedside instrument.
1. The 10 Components of the Malnutrition Inflammation Score
The MIS evaluates 10 distinct components, each assigned a score from 0 (normal / no impairment) to 3 (severe impairment). Summing the individual scores yields an aggregate MIS ranging from 0 (optimal nutritional and non-inflammatory state) to 30 (extreme, life-threatening wasting and inflammation).
Detailed Scoring Breakdown Across the 10 Components
| # | Component | Score 0 (Normal) | Score 1 (Mild) | Score 2 (Moderate) | Score 3 (Severe) |
|---|---|---|---|---|---|
| 1 | Dry Weight Change (over past 3–6 months) | < 0.5 kg loss | 0.5 to 1.0 kg loss | > 1.0 kg loss, but < 5% of body weight | ≥ 5% loss of body weight |
| 2 | Dietary Intake | Good / habitual solid diet; normal intake | Slightly suboptimal solid diet; minor anorexia | Moderately suboptimal solid diet or full liquid diet | Severe hypocaloric liquid diet or near-starvation |
| 3 | Gastrointestinal Symptoms | None, or rare occasional symptoms | Mild symptoms (occasional nausea, mild early satiety) | Moderate symptoms (frequent nausea, vomiting, or diarrhea) | Severe, daily intractable vomiting, anorexia, or diarrhea |
| 4 | Functional Capacity | Normal functional capacity; vigorous/independent | Difficulty with heavy work or strenuous ambulation | Difficulty with light work; mostly sedentary lifestyle | Bedridden or wheelchair-bound; dependent for ADLs |
| 5 | Comorbidity (CCI + Vintage) | Mild/no comorbidity; on dialysis < 1 year | Moderate comorbidity OR on dialysis 1 to 4 years | Severe comorbidity OR on dialysis > 4 years | Very severe comorbidity (e.g., severe CHF, metastatic cancer, sepsis) |
| 6 | Subcutaneous Fat Loss (orbital, triceps, biceps, chest) | Normal; full fat cushions, normal pinch thickness | Mild loss; slight decrease in skinfold thickness | Moderate loss; hollow eye sockets, reduced fat pinch | Severe loss; near-total absence of subcutaneous adipose tissue |
| 7 | Muscle Wasting (temple, clavicle, scapula, ribs, knee, interosseous) | Normal muscle bulk; firm, convex contours | Mild wasting; slight temple flattening, clavicle visible | Moderate wasting; hollow temples, prominent clavicles/scapula | Severe wasting; hollow scooped temples, skeletal 'coat-hanger' appearance |
| 8 | Body Mass Index (BMI) | ≥ 20.0 kg/m² | 18.0 to 19.99 kg/m² | 16.0 to 17.99 kg/m² | < 16.0 kg/m² |
| 9 | Serum Albumin | ≥ 4.0 g/dL | 3.5 to 3.9 g/dL | 3.0 to 3.4 g/dL | < 3.0 g/dL |
| 10 | Serum TIBC (Total Iron Binding Capacity) | ≥ 250 mg/dL | 200 to 249 mg/dL | 150 to 199 mg/dL | < 150 mg/dL |
2. In-Depth Rationale for Biochemical Parameters in MIS
Unlike traditional SGA, which is purely qualitative, the inclusion of objective biochemical parameters in MIS provides vital diagnostic and prognostic power:
A. Serum Albumin Thresholds
Serum albumin is a negative acute-phase reactant with a circulating half-life of approximately 20 days. In maintenance dialysis, circulating albumin levels are regulated by a balance between hepatic synthesis, transcapillary escape, dialytic losses, and catabolism. Pro-inflammatory cytokines (IL-6, TNF-α) suppress hepatic albumin gene transcription while increasing vascular permeability. In the MIS, an albumin < 3.0 g/dL receives the maximum score of 3, directly capturing severe visceral depletion and intense systemic inflammation.
B. Serum Total Iron Binding Capacity (TIBC) as a Visceral Protein & Inflammatory Marker
Many clinicians overlook the biochemical rationale for including TIBC in a nutritional assessment score:
- Surrogate for Serum Transferrin: In clinical laboratories, transferrin is frequently not ordered directly due to cost. However, TIBC directly reflects circulating transferrin according to the established biochemical relationship:
Serum Transferrin (mg/dL) ≈ Serum TIBC (mg/dL) * 0.7 to 0.8(or conversely,TIBC ≈ Transferrin * 1.38 to 1.45). - Rapid Kinetic Response: Transferrin has a much shorter half-life (~8 days) than albumin (~20 days), making TIBC a more agile and rapid responder to acute protein starvation and recovery.
- Dual Nutritional and Inflammatory Indicator: Transferrin is a powerful negative acute-phase protein. During chronic microinflammation, elevated hepcidin and cytokine activity trap iron within the reticuloendothelial system while the liver drastically downregulates transferrin synthesis. A TIBC < 150 mg/dL (Score 3) signifies severe visceral protein depletion compounded by intense, unyielding cytokine activation.
3. Clinical Interpretation and Prognostic Stratification
Summing the 10 components yields an objective score that stratifies patients into actionable prognostic tiers:
MIS RISK STRATIFICATION
[ 0 -------------- 5 ] [ 6 -------------- 8 ] [ 9 ----------------------------- 30 ]
Low Nutritional Risk Moderate Malnutrition Severe PEW & High Inflammation
• Excellent visceral stores • Mild somatic/visceral loss • Profound muscle & fat wasting
• Low systemic inflammation • Emerging inflammatory drive • High hs-CRP and Interleukin-6
• High ESA responsiveness • Moderate ESA resistance • Severe ESA Hyporesponsiveness
• Lowest risk • Warrants oral supplements • Highest hospitalization & death risk
Interpreting the Score (Teaching Bands)
The MIS has no single official cut point. Studies have used thresholds such as 5 or more, or above 8, and each additional point is associated with higher hospitalization and mortality risk. Use the bands below as a practical teaching guide, not as validated categories:
- Score 0 to 5 (Lower Risk): Adequate somatic and visceral reserves and a low inflammatory burden.
- Score 6 to 8 (Moderate Risk): Early, progressive PEW and emerging microinflammation. This is the critical therapeutic window for the renal dietitian: initiating oral nutritional supplements (ONS) or aggressive anti-inflammatory management at this stage can prevent progression to irreversible cachexia.
- Score > 8 (Severe PEW & High Inflammatory Risk):
- Erythropoietin Resistance: Scores > 8 correlate strongly with Erythropoietin Resistance Index (ERI) elevation. Patients require massively escalated doses of erythropoiesis-stimulating agents (ESAs) to maintain target hemoglobin because inflammatory cytokines blunt erythroid progenitor proliferation and disrupt iron utilization.
- Mortality and Hospitalization: Higher MIS values are independently associated with hospitalization and all-cause and cardiovascular death in dialysis cohort studies.
4. Head-to-Head Comparison: MIS vs. 7-Point SGA vs. ISRNM Criteria
To excel on the CDR Specialist in Renal Nutrition (CSR) examination, dietitians must know how and when to deploy these three major assessment tools:
| Assessment Instrument | Scoring Architecture | Parameters Included | Primary Clinical Strengths | Primary Limitations |
|---|---|---|---|---|
| Malnutrition Inflammation Score (MIS) | Quantitative continuous scale (0 to 30) across 10 components | Medical history, physical exam, BMI, serum albumin, serum TIBC | Superior prognostic discrimination for mortality; captures both wasting and inflammation; ideal for tracking response to ONS/IDPN | Requires concurrent lab draws (albumin, TIBC); cannot be completed purely at bedside without lab access |
| 7-Point KDOQI SGA | Semi-quantitative Likert scale (1 to 7) based on holistic clinical judgment | Medical history (weight, diet, GI, function, stress) and physical exam (fat, muscle, edema) | Pure bedside execution without relying on lab values; immune to fluid shifts if dry weight is used; highly validated | Qualitative elements create inter-observer variability; lacks objective biochemical/inflammatory markers |
| ISRNM Consensus PEW Criteria | Categorical diagnostic classification (Must meet ≥ 1 criterion in ≥ 3 of 4 categories) | Serum chemistry (albumin, prealbumin, cholesterol), BMI/weight, muscle mass/MAMC, dietary intake (nPCR, DEI) | Establishes formal, internationally standardized diagnostic definition for clinical trials and epidemiology | Categorical (Yes/No) format cannot grade subtle severity or track micro-responses to nutrition support |
In the 10-component Malnutrition Inflammation Score (MIS), which biochemical and physiological rationale justifies the inclusion of serum Total Iron Binding Capacity (TIBC) alongside serum albumin?
Serum TIBC directly quantifies adherence to calcium-based phosphate binders, where levels below 150 mg/dL indicate severe gastrointestinal binder binding failure.
Serum TIBC acts as a positive acute-phase reactant that rises sharply during systemic microinflammation, balancing the negative acute-phase behavior of albumin.
Serum TIBC serves as an objective surrogate for serum transferrin, reflecting rapid visceral protein changes and cytokine-mediated hepatic suppression due to its shorter half-life.
Serum TIBC provides an accurate surrogate for peritoneal glucose transport rate, allowing clinicians to calculate daily dialytic carbohydrate absorption in peritoneal dialysis.
A maintenance hemodialysis patient has an aggregate Malnutrition Inflammation Score (MIS) of 15. Which clinical profile and prognostic risk pattern are most consistent with this score?
Normal nutritional status with isolated severe iron deficiency, carrying minimal 1-year hospitalization or mortality risk.
Mild protein malnutrition that can be completely resolved within 2 weeks by increasing dialyzer blood flow rate without nutritional supplementation.
Well-controlled cardiorenal status with low systemic inflammatory cytokines, indicative of high erythropoietin sensitivity and excellent 2-year survival.
Severe Protein-Energy Wasting combined with active systemic microinflammation, accompanied by marked erythropoietin resistance and significantly elevated 1-year mortality.
When comparing the Malnutrition Inflammation Score (MIS), the KDOQI 7-point Subjective Global Assessment (SGA), and the ISRNM consensus criteria for PEW, which statement accurately distinguishes their clinical design and application?
The MIS generates a continuous quantitative score (0–30) integrating clinical history, physical exam, and objective laboratory markers (albumin, TIBC), whereas the 7-point SGA relies strictly on medical history and physical exam without lab values.
The 7-point SGA incorporates serum prealbumin and cholesterol into a 7-point algorithm, whereas the MIS completely omits hands-on physical examination components.
The ISRNM consensus criteria produce a granular 30-point scoring scale designed for weekly clinical tracking, whereas the MIS is restricted to qualitative classification into stages A, B, and C.
Both the MIS and the 7-point SGA mandate dual-energy X-ray absorptiometry (DXA) scans to confirm muscle wasting, whereas ISRNM criteria rely exclusively on serum biochemistry.
Sections you finish are checked off in the contents.